FONTENOT JASON D. (SVP, Chief Scientific Officer) reported 1 transaction at SANGAMO THERAPEUTICS, INC
Review the transaction codes below to understand the nature of each event.
Filed: 11/28/2023ACC: 0001209191-23-056783
Officer· SVP, Chief Scientific Officer
Since Mar 2021
-1.03K
Net shares
Net seller
$393.56
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.03K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.03K
Price / share
$0.38
Trade value
$393.56
% of position
0.8%
11/25/2023
137.30K→136.27K
Total
Net shares
−1.03K
Net value
-$393.56
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/25/2023 | F · Tax Withholding | −1.03K | $0.38 | $393.56 | 0.8% | 137.30K | 136.27K |
| Total | −1.03K | -$393.56 | ||||||
Derivative Transactions0
No derivative transactions reported